RediChew Rx

Product Overview

Product Image

Brand: vitaMedMD

Barcode: 3 10782-301-30 2

Net Contents: 30 Chewable Tablet(s)

Serving Size (Overview): 1 Chewable Tablet(s)

Product Type: Vitamin [A1302]

Form: Tablet or Pill [E0155]

Date Entered: Mar 25, 2021

Market Status: On Market

Suggested Use (Overview): Suggested use: As a dietary supplement for women planning a pregnancy and for pregnant women with difficulty swallowing tablets or capsules; or where nausea or morning sickness makes taking tablets or capsules difficult; take one chewable tablet daily.

Product Self-Roles:

  • No specific self-roles defined.

Dietary Supplement Facts

Ingredient Category Amount Per Serving Unit % Daily Value Target Group Serving Size (Fact)
Vitamin D3 vitamin 400 IU 100 Pregnant and Lactating 1 Chewable Tablet(s)
Vitamin B2 vitamin 1.7 mg 85 Pregnant and Lactating 1 Chewable Tablet(s)
Vitamin B6 vitamin 2 mg 80 Pregnant and Lactating 1 Chewable Tablet(s)
Folate vitamin 1 mg 125 Pregnant and Lactating 1 Chewable Tablet(s)
Quatrefolic non-nutrient/non-botanical 600 mcg N/A N/A 1 Chewable Tablet(s)
Folic Acid vitamin 400 mcg N/A N/A 1 Chewable Tablet(s)
Vitamin B12 vitamin 8 mcg 100 Pregnant and Lactating 1 Chewable Tablet(s)

Other Ingredients

Mannitol; Natural masking flavor; natural Vanilla flavor; Magnesium Stearate; Silica

Label Statements

Other

  • Product code 10782-301-30 N

Formulation

  • With Quatrefolic Chewable prenatal multivitamin Doctor-recommended for women planning a pregnancy and pregnant women with difficulty swallowing tablets or capsules Gluten lactose and sugar-free

Statement of Identity

  • Dietary Supplement

Suggested Use

  • Suggested use: As a dietary supplement for women planning a pregnancy and for pregnant women with difficulty swallowing tablets or capsules or where nausea or morning sickness makes taking tablets or capsules difficult take one chewable tablet daily.

Precautions

  • For adults only. Consult your doctor before taking any supplement. Keep this product out of the reach of children. Warning: Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient. Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive.Contraindications: This product is contraindicated in patients with known hypersensitivity to any of the ingredients.

Branding Statement(s)

  • Quatrefolic is a registered trademark of Gnosis Spa.U.S. Patent No. 7947662 and other patents pending.

Product Specific Information

  • Keep in a cool dry place tightly closed.

Associated Company Information & Roles

TherapeuticsMD

951 Broken Sound Pkwy NW #320, Boca Raton, FL 33487

Roles for this Product:

  • Distributor